3-Months Postoperative Clinical Evaluation Of The Multifocal Maxvision Iol

To evaluate the refractive and visual results obtained with the mutlifocal (hybrid:bifocal and with negative asphericity modulation) intraocular implant  MaxVision® (designed by Ophthalmo Pro, St-Ingbert, Germany).

 This retrospective single-center study evaluates the visual results obtained 3 months after cataract surgery and bilateral implantation of the MaxVision®. 

12 patients who received a MaxVision IOL in both eyes  were enrolled in the study, excluding ocular pathologies that could limit visual results. After 3 months, uncorrected and distance-corrected acuities were evaluated for distance (3.5 m, corrected at infinity), intermediate (66 cm), and near vision (40 cm). Monocular and binocular curves were measured (range from +1.5 D to -3.5 D in 0.5 D steps) and contrast sensitivity under photopic and mesopic conditions was also assessed. Finally, patients were asked to complete a postoperative satisfaction survey, including spectacle independence and visual symptoms assessment (modified CATQuest-9SF, PRSIQ, and PRVSQ questionnaire).

Data still under collection.

This new type of multifocal implant makes it possible to retain functional vision of infinity at 40 cm in an almost continuous manner, while limiting the photic effects associated with diffraction. This new concept also makes it possible to retain good contrast sensitivity in scotopic conditions.